emtricitabine has been researched along with alovudine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, HK; Chhikara, BS; Doncel, GF; Parang, K; Quiterio, M | 1 |
Agarwal, HK; Chhikara, BS; Doncel, GF; Parang, K | 1 |
Otto, MJ | 1 |
Agarwal, HK; Doncel, GF; Malekar, S; Oh, D; Parang, K; Pemmaraju, BP; Tiwari, RK; Worthen, DR | 1 |
1 review(s) available for emtricitabine and alovudine
Article | Year |
---|---|
New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Cytidine Triphosphate; Deoxycytidine; Dideoxynucleosides; Dioxolanes; Emtricitabine; HIV Infections; Humans; Purine Nucleosides; Reverse Transcriptase Inhibitors; Thionucleosides; Zalcitabine | 2004 |
3 other study(ies) available for emtricitabine and alovudine
Article | Year |
---|---|
Synthesis and anti-HIV activities of glutamate and peptide conjugates of nucleoside reverse transcriptase inhibitors.
Topics: Acetates; Anti-HIV Agents; Cell Line; Drug Resistance, Multiple, Viral; Esters; Glutamates; HIV-1; Humans; Myristic Acids; Nucleosides; Oligopeptides; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2012 |
Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Dicarboxylic Acids; Esters; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nucleosides; Reverse Transcriptase Inhibitors | 2017 |
Design, synthesis, antiviral activity, and pre-formulation development of poly-L-arginine-fatty acyl derivatives of nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell-Penetrating Peptides; Deoxycytidine; Deoxyribonucleosides; Dicarboxylic Acids; Dideoxynucleosides; Emtricitabine; Humans; Lamivudine; Peptides; Reverse Transcriptase Inhibitors | 2015 |